Sofiva Genomics Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sofiva Genomics Co Ltd with three other
companies in this sector in TAIWAN :
Medigen Biotechnology Corporation
sales of 552.35 million Taiwanese Dollars [US$19.36 million]
of which 66%
was Drug Discovery),
Genomics Biosci &Tech Co Ltd
(427.65 million Taiwanese Dollars [US$14.99 million]
Sunmax Biotechnology Co Limited
(594.15 million Taiwanese Dollars [US$20.82 million]
of which 84%
was China Mainland).
Sofiva Genomics Co Ltd reported sales of 509.45 million Taiwanese Dollars (US$17.86 million)
December of 2019.
increase of 10.9%
versus 2018, when the company's sales were 459.40 million Taiwanese Dollars .
Sales at Sofiva Genomics Co Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 73%).